Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at USArmy.Detrick.MEDCOM-USAMRMC.List.ORTA@health.mil



COBALT HEXAMMINE AS A POTENTIAL THERAPEUTIC AGAINST HIV AND/OR EBOLA VIRUS

Hexaamminecobalt(III) chloride, also called Cohex, reduces the extent of viral infection, including difficult to treat infections caused by Ebola virus and HIV. Disclosed are methods for treating a viral infection, comprising administering to a patient a cobalt(III) hexammine compound in an amount effective to reduce an extent of a viral infection. Also disclosed are kits for delivery of a cobalt(III) hexammine compound by injection.


Docket:RIID 2011-16

Publication/Issued No.:2011-0027388

Publication/Issue Date:2011-02-03

Categories: Therapeutic

More Detail:Visit USPTO.GOVExternal link

Lab:RIID

Inventor(s):CHANG, E.; HENSLEY, L.; THACH, D.; OLINGER, G.; KNIGHT, A.


For Licensing Opportunities, please contact the ORTA at USArmy.Detrick.MEDCOM-USAMRMC.List.ORTA@health.mil
 

Last Modified Date: 25 Jul 2023

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRDC Public Affairs Office at:
USArmy.Detrick.MEDCOM-USAMRMC.List.ORTA@health.mil or by telephone at (301)619-2736.